Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Active, not recruitingOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

April 11, 2027

Study Completion Date

April 11, 2027

Conditions
Endometrial CarcinomaMalignant Uterine NeoplasmUterine Corpus CancerUterine Corpus Sarcoma
Interventions
OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT04634617 - Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors | Biotech Hunter | Biotech Hunter